According to Cognitive Market Research, the global Plasmid DNA CDMO Market size was USD 275.9 million in 2024. It will expand at a compound annual growth rate (CAGR) of 20.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 110.36 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 82.77 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 63.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 13.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 5.52 million in 2024 and will grow at a compound annual growth rate (CAGR) of 20.2% from 2024 to 2031.
The less than 200 mL category is the fastest growing segment of the Plasmid DNA CDMO industry
